Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.

The funding market, moving in real timeGet StartedBook a Demo
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Immunomic Therapeutics announced it raised $6.5 Million in an initial filing from an offering of $16 Million

PRIVATEJun 02, 2025about 1 year ago

Amount Raised

$6.5 Million

Round Type

Venture - Series Unknown

RockvilleBiotechnology

Company Information

Company

Immunomic Therapeutics, Inc.

Location

ATTN: C. Eric Winze, 15010 BROSCHART RD.

Rockville, Maryland, United States

About

The privately-held biotechnology company is pursuing the development of innovative Chimeric Antigen Receptor T-cell (CAR-T) therapies for the treatment of refractory cancers and solid tumors. It has established proof of concept data demonstrating the therapeutic potential for the treatment of multiple solid tumors, including colorectal, pancreatic, mesothelioma, ovarian and breast cancer.

Related People

Suggested for you
2 contacts

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Immunomic Therapeutics, Inc.'s next move

Learn about Strategic plan

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.

Watching Immunomic Therapeutics, Inc.? See every signal — funding, hires, M&A, contracts, sentiment.

Book a demoChoose your plan